Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Pre-Cold Medicine Products
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Class-Action Tracker
Zicam Products
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Zicam Pre-Cold Remedies
The Latest
2026 Deceptive Ad Trends
A closer look at what we’ll be monitoring in the new year.
Why ‘Click-to-Cancel’ Still Matters – and Why the FTC Should Try Again
The problem hasn’t gone away.
Amazon’s Great Holiday Climb
Why parents may need to be called in to this Roblox game rated 13+.
Interior Icons’ 10-Year Warranty and 365-Day Returns
Taking advantage of these perks may be harder than advertised.
TINA.org’s Year in Review 2025
Looking back at our accomplishments